Author:
Igarashi Masahiko,Hirata Akihiko,Yamaguchi Hiroshi,Sugae Naoko,Kadomoto Yuko,Jimbu Yumi,Daimon Makoto,Kato Takeo,Tominaga Makoto
Publisher
Japan Atherosclerosis Society
Subject
Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine
Reference35 articles.
1. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
2. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
3. Surrogate End Points, Health Outcomes, and the Drug-Approval Process for the Treatment of Risk Factors for Cardiovascular Disease
4. (4) Sacco RL, Wolf PA, and Gorelick PB: Risk factors and their management for stroke prevention: Outlook for 1999 and beyond. Neurology, 53: S15−S24, 1999
5. (5) Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, and Riley W: Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation, 102: 1503−1510, 2000
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献